Abstract
Background: Hypothalamic amenorrhea (HA) is characterized by neuroendocrine impairment that, in turn, negatively modulates endocrine function, mainly within the reproductive axis. HA presents with hypo-LH, hypoestrogenism and, until now, a definite therapeutic strategy has not yet been found. The aim of the following study was to test the efficacy of acetyl-L-carnitine (ALC) administration in HA-affected subjects. Population: Twenty-four patients affected by stress-induced HA were divided into two groups according to LH plasma levels: group A, hypo-LH (LH≤3 mIU/ml; no.=16), and group B, normo-LH (LH>3 mIU/ml; no.=8), were treated with ALC (1 g/day, per os) for 16 weeks. Design: Patients underwent baseline hormonal assessment, pulsatility test (for LH and FSH), naloxone test (for LH, FSH and cortisol) both before and after 16 weeks of treatment. Results: Under ALC administration hypo-LH patients showed a significant increase in LH plasma levels (from 1.4±0.3 to 3.1 ±0.5 mIU/ml, p<0.01 ) and in LH pulse amplitude (p<0.001). No changes were observed in the normo-LH group. LH response to naloxone was restored under ALC therapy. Maximal LH response and area under the curve under naloxone were significantly increased (p<0.05 and p<0.01, respectively). No changes were observed in the normo-LH patients. Conclusions: Our data support the hypothesis of a specific role of ALC on counteracting the stress-induced abnormalities in hypo-LH patients affected by hypothalamic amenorrhea.
Similar content being viewed by others
References
Genazzani AD. Neuroendocrine aspects of amenorhea related to stress. Ped End Rev 2005, 2: 661–8.
Meczekalski B, Podfigurna-Stopa A, Warenik-Szymankiewicz, Genazzani AR. Functional hypothalamicamenorrhea: current view on neuroendocrine aberrations. Gynecol Endocrinol 2008, 24: 4–11.
Yen SSC. Effects of lifestyle and body composition on the ovary. Endocrinol Metab Clin North Am 1998, 27: 915–26.
Berga SL, Mortola SF, Girton L, et al. Neuroendocrine aberrations in women with functional hypothalamic amenorrhea. J Clin Endocrinol Metab 1989, 68: 301–8.
Genazzani AD, Petraglia F, Volpe A, Genazzani AR. Hypothalamic amenorrhea: neuroendocrine mechanisms/stress-induced anomalies. Ass ReprTech Andr 1997, 9: 1–13.
Genazzani AD, Gastaldi M, Volpe A, Petraglia F, Genazzani AR. Spontaneous episoidc release of adenohypophyseal hormones in hypothalamicamenorrhea. Gynecol Endocrinol 1995, 9: 325–34.
Genazzani AD, Petraglia F, Benatti R, et al. Luteinizing hormone secretory burst duration is independent from luteinizing hormone, prolactin orgonadal steroid plasma levels in amenorrheic women. J Clin Endocrinol Metab 1991, 72: 1220–5.
Genazzani AD, Petraglia F, Fabbri G, Monzani A, Montanini V, Genazzani AR. Evidence of luteinizing hormone pulsatile secretion in hypothalamic amenorrhea associated with weight loss. Fertil Steril 1990, 54: 222–6.
Dobson H, Ghuman S, Prabhakar S, Smith R. A conceptual model of the influence of stress on female reproduction. Reproduction 2003, 125: 151–63.
Genazzani AD, Petraglia F, Gastaldi M, Volpogni C, Gamba O, Genazzani AR. Naltrexone treatment restores menstrual cycles in patients with weight loss-related amenorrhea. Fertil Steril 1995, 64: 951–6.
Bidzinska B, Petraglia F, Angioni S, et al. Effect of different chronic intermittent stressors and acetyl-l-carnitine on hypothalamic beta-endorphin and GnRH and on plasma testosterone levels in male rats. Neuroendocrinology 1993, 57: 985–90.
Onofrj M. Bodis-Wollner I, Pola P, Calvani M. Central cholinergic effects of levo-acrtyl-carnitine. Drugs Exp Clin Res 1983, 9: 161–9.
Janiri L, Tempesta E. A pharmacological profile of the effects of carnitine and acetyl-l-carnitine on the central nervous system. In J Clin Pharmacol Res 1983, 3: 295–306.
Tempesta E, Janiri L, Pirroncelli C. Stereospecific effects of acetyl-l-carnitine on the spontaneous activity of brainstem neurones and their response to acetylcholine and serotonin. Neuropharmacology 1985, 24: 43–50.
Genazzani AR, De Ramundo B, Criscuolo M, et al. Acetyl-l-carnitine restores the daily pattern of hypothalamic β-endorphin in rats exposed to continuous light. Europ J Pharmacol 1990, 186: 177–80.
Bidzinska B, Petraglia F, Angioni S, et al. Acetyl-L-carnitine effect on pituitary and plasma beta-endorphin responsiveness to different chronic intermittent stressors. J Neuroendocrinol 1993, 5: 151–5.
Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic and therapeutic properties: relevance for its mode of action in Alzheimer’s disease and geriatric depression. Mol Psychiatry 2000, 5: 616–32.
Genazzani AD, Petraglia F, Algeri I, et al. Acetyl-L-Carnitine as possible drug in the treatment of hypothalamic amenorrhea. Acta Obstet Gynecol Scand 1991, 70: 487–92.
American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th ed. Washington, DC: American Psychiatric Association, 1995.
Genazzani AD, Petraglia F, Fabbri G, Monzani A, Montanini V, Genazzani AR. Evidence of luteinizing hormone secretion in hypothalamic amenorrhea associated with weight loss. Fertil Steril 1990, 54: 222–6.
Genazzani AD, Petraglia F, Pianazzi F, Volpogni C, Genazzani AR. The concomitant release of androstenedione with cortisol and luteinizing hormone pulsatilee releases distinguishes adrenal from ovarian hyperandrogenism. Gynecol Endocrinol 1993, 7: 33–41.
Oerter KE, Guardabasso V, Rodabrd D. Detection and characterization of peaks and estimation of instantaneous secretory rate for episodic pulsatile hormone secretion. Computers and Biomedical Research 1986, 19: 170–91.
Genazzani AD. Application of peak-detection programs to clinical data. In: Guardabasso V, Rodbard D, Forti G eds. Computers in Endocrinology: Recent Advances. New York: Raven Press. 1990, 71–82.
Genazzani AD, Rodbard D. Evaluation of methods for detection of pulsatile hormone secretion: sensitivity vs. specificity. Acta Endocrinol (Copenh) 1991, 124: 295–306.
Nappi RE, Petraglia F, Genazzani AD, D’Ambrogio G, Zara C, Genazzani AR. Hypothalamic amenorrhea: evidence for a central derangement of hypothalamic-pituitary-adrenal cortex axis activity. Fertil Steril 1993, 59: 571–6.
Bertoni-Freddari C, Fattoretti P, Casoli T, Spagna C, Casell U. Dynamic morphology of the synaptic junctional areas during aging: the effect of chronic acetyl-L-carnitine administration. Brain Res 1994, 656: 359–66.
Bertoni-Freddari C, Fattoretti P, Caselli U, Paoloni R. Acetylcarnitine modulation of the morphology of rat hippocampal synapses. Anal Quant Cytol Histol 1996, 18: 275–8.
Onofrj M, Bodis-Wollner I, Pola P, Calvani M. Central cholinergic effects of levo-acetylcarnitine. Drugs Exp Clin Res 1983, 9: 161–9.
Genazzani AD, Battaglia C, Malavasi B, Strucchi C, Tortolani F, Gamba O. Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome. Fertil Steril 2004, 81: 114–8.
Genazzani AD, Petraglia F, Volpogni C, D’Ambrogio G, Facchinetti F, Genazzani AR. FSH secretory pattern and degree of concordance with LH in amenorrheic, fertile and postmenopausal women. Am J Physiol 1993, 264: E776–81.
Pettegrew JW, Levine J, McClure RJ. Acetyl-L-carnitine physical-chemical, metabolic, and therapeutic properties: relevance for its mode of action in Alzheimer’s disease and geriatric depression. Molecular Psychiatry 2000, 5: 616–32.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Genazzani, A.D., Lanzoni, C., Ricchieri, F. et al. Acetyl-L-carnitine (ALC) administration positively affects reproductive axis in hypogonadotropic women with functional hypothalamic amenorrhea. J Endocrinol Invest 34, 287–291 (2011). https://doi.org/10.1007/BF03347087
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03347087